Has Rachel Hargrove, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,653 in general payments to Rachel Hargrove, MD across 163 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachel Hargrove, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachel Hargrove, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachel Hargrove, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Fountain Valley, CANPI 1871812727

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Edwards Lifesciences at 38.3% of the total. Reporting peaked in 2022 at $3,902 and has fallen 76.8% since, to $905 in 2025.

$13,653in general payments, 2019–2025

Across 163 payments — averaging $83.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$5K
Atricure, Inc.$4K
Abiomed$2K
Abbott$1K
Medtronic$936
Davol Inc.$158
plus $545 from 8 others

What the payments were for

Consulting fees$2,40018%
Travel & lodging$3,18123%
Food & beverage$8,04359%
Education$290%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	47	$5,229
Atricure, Inc.	57	$4,056
Abiomed	14	$1,574
Abbott	12	$1,155
Medtronic	14	$936
Davol Inc.	3	$158
Solventum Corporation	2	$136
Johnson & Johnson	4	$104
KCI USA, Inc.	2	$98
Cardiva Medical, Inc.	3	$60
Elutia, Inc.	1	$58
Artivion, Inc.	2	$38
W. L. Gore & Associates, Inc.	1	$37
Cardiovascular Systems Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Impella$1,159
Edwards SAPIEN 3 Transcatheter Heart Valve$969
SYNERGY ABLATION SYSTEM$843
Epic$796
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$479
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$275
ATRICLIP LAA EXCLUSION SYSTEM$228
COREVALVE EVOLUT R$215
HANCOCK II$197
SAPIEN 3 Ultra RESILIA$191
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$158
INSPIRIS RESILIA aortic valve$157
KONECT RESILIA$153
Avalus$150
2ND GEN CENTRIMAG PRIMARY CONSOLE$125
PREVENA$117
V.A.C. ULTA$117
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$112

How this compares

$13,653 in reported general payments places this provider in the 70th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Medicare billing

Part B allowed, 2024

$57,175

Medicare patients

Services billed

157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Fountain Valley

Reginald AbrahamFountain Valley$181K
Thomas FogartyPortola Valley$3.7M
Steven GundryPalm Springs$1.6M
Armin KiankhooySaint Helena$941K
Ara KlijianMurrieta$916K
Gregory FontanaThousand Oaks$875K
Gansevoort DunningtonSaint Helena$764K
Wilson TsaiWalnut Creek$680K
Fernando FleischmanLos Angeles$608K
Harmik SoukiasianLos Angeles$577K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →